The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-analysis
Open accessAbstract
OBJECTIVE: Previous meta-analyses identified an inverse association of coffee consumption with the risk of type 2 diabetes. However, an updated meta-analysis is needed because new studies comparing the trends of association for caffeinated and decaffeinated coffee have since been published. RESEARCH DESIGN AND METHODS: PubMed and Embase were searched for cohort or nested case-control studies that assessed the relationship of coffee consumption and risk of type 2 diabetes from 1966 to February 2013. A restricted cubic spline random-effects model was used. RESULTS: Twenty-eight prospective studies were included in the analysis, with 1,109,272 study participants and 45,335 cases of type 2 diabetes. The follow-up duration ranged from 10 months to 20 years. Compared with no or rare coffee consumption, the relative risk (RR; 95% CI) for diabetes was 0.92 (0.90–0.94), 0.85 (0.82–0.88), 0.79 (0.75–0.83), 0.75 (0.71–0.80), 0.71 (0.65–0.76), and 0.67 (0.61–0.74) for 1–6 cups/day, respectively. The RR of diabetes for a 1 cup/day increase was 0.91 (0.89–0.94) for caffeinated coffee consumption and 0.94 (0.91–0.98) for decaffeinated coffee consumption (P for difference = 0.17). CONCLUSIONS: Coffee consumption was inversely associated with the risk of type 2 diabetes in a dose-response manner. Both caffeinated and decaffeinated coffee was associated with reduced diabetes risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both caffeinated and decaffeinated coffee associate with lower onset of diabetes in a dose-dependent fashion (Figure 6).269”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [269]
In the citing paper
“Coffee intake also associates with lower risk of CHD and stroke but in a nonlinear fashion: compared with no intake, lowest risk is seen at 3-4 cups/day, with increasing risk at higher intakes.270”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [270]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“For each group, a random-effects model was used to pool the RR of type 2 diabetes (25).”
MethodWild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · cited 1×
“The worldwide prevalence of type 2 diabetes is increasing, and the global number of people with diabetes is estimated to reach 366 million by the year 2030 (1).”
BackgroundMethods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353 · cited 1×
“For the parametric method, a randomeffects dose-response meta-analysis was performed (26).”
MethodLong-Term Complications of Diabetes Mellitus
Nathan, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282306 · Cited by 1,495
Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review
van Dam, R. M., & Hu, F. B. (2005) · JAMA · doi:10.1001/jama.294.1.97 · Cited by 662 · cited 1×
“van Dam and Hu (14) included nine cohort studies and reported a lower risk of type 2 diabetes for high coffee consumption compared with no coffee consumption with little between-study heterogeneity.”
BackgroundSelf-citationCoffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus
Huxley, R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.439 · Cited by 476 · cited 2×
“(15) included only six studies on decaffeinated coffee, and estimates were less precise than for caffeinated coffee because of lower consumption levels.”
BackgroundIso, H., Date, C., Wakai, K., Fukui, M., Tamakoshi, A., & and the JACC Study Group* (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-8-200604180-00005 · Cited by 462
Coffee consumption and risk for type 2 diabetes mellitus
Salazar-Martinez, E., Willett, W. C., Ascherio, A., Manson, J. E., Leitzmann, M. F., Stampfer, M. J., & Hu, F. B. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00005 · Cited by 462
Self-citationMagnesium Intake and Risk of Type 2 Diabetes in Men and Women
López‐Ridaura, R., Willett, W. C., Rimm, E. B., Liu, S., Stampfer, M. J., Manson, J. E., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.134 · Cited by 455
Self-citationCoffee consumption and risk of type 2 diabetes mellitus
van Dam, R. M., & Feskens, E. J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11436-x · Cited by 444
Flagged first, then by citations
1 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
Self-citationMozaffarian, D. (2016) · Circulation · doi:10.1161/circulationaha.115.018585 · Cited by 2,216
“Both caffeinated and decaffeinated coffee are associated with lower onset of diabetes mellitus in a dose-dependent fashion (Figure 6).(269) Coffee intake also is associated with lower risk of CHD and stroke but in a nonlinear fashion: in comparison with no intake, the lowest risk is seen at 3 to 4 cups/d, with increas…”
Treatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347
Prevention and management of type 2 diabetes: dietary components and nutritional strategies
Ley, S. H., Hamdy, O., Mohan, V., & Hu, F. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60613-9 · Cited by 1,301
Self-citationCoffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
Poole, R., Kennedy, O. J., Roderick, P., Fallowfield, J. A., Hayes, P. C., & Parkes, J. (2017) · BMJ · doi:10.1136/bmj.j5024 · Cited by 835
“The associations between high versus low consumption of decaffeinated coffee and lower risk of type 2 diabetes 21 and endometrial cancer 40 were of a similar magnitude to total or caffeinated coffee, and there was a small beneficial association between decaffeinated coffee and lung cancer.”
Background
Metadata
- Authors
- Ding, M., Bhupathiraju, S. N., Chen, M., van Dam, R. M., & Hu, F. B.
- Affiliations
- Harvard University (US)
- Department of Nutrition, Harvard School of Public Health, Boston, MA
- Brigham and Women's Hospital (US)
- Corresponding author
- Hu, Frank B.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-01-11
- Volume
- 37
- Issue
- 2
- Pages
- 569-586
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3898757
- OpenAlex
- W2100404723
- Cited by
- 511
- References
- 45
- Citations by year
- 2026: 23 · 2025: 24 · 2024: 44 · 2023: 33 · 2022: 39 · 2021: 41 · 2020: 46 · 2019: 37 · 2018: 72 · 2017: 53 · 2016: 53 · 2015: 32 · 2014: 12
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845, DK58845)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- coffee consumption, type 2 diabetes, caffeinated coffee, decaffeinated coffee, dose-response relationship
- MeSH terms
- Caffeine, Coffee, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
